The observation that loss of perivascular AQP4 localization in post mortem human tissue is a feature of AD and associates with both Alzheimer’s pathology and cognitive/functional decline early in the disease process suggest that these mechanisms may be key drivers in the development and progression of Alzheimer’s disease in human populations. Here, AQP4 is linked to early-onset autosomal dominant Alzheimer disease.